Walleye Trading LLC Prothena Corp Public LTD CO Put Options Transaction History

Walleye Trading LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $619,630 - $924,859	13,100 Added 818.75%	14,700 $709,000
Q2 2023 Aug 14, 2023	SELL	$48.26 - $78.59 $1.85 Million - $3.02 Million	-38,400 Reduced 96.0%	1,600 $109,000
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $1.88 Million - $2.33 Million	40,000 New	40,000 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$42.11 - $73.26 $442,155 - $769,230	-10,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $506,100 - $828,345	10,500 New	10,500 $748,000
Q2 2021 Aug 16, 2021	SELL	$21.63 - $57.65 $216,300 - $576,500	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.0 - $28.24 $170,500 - $437,720	-15,500 Reduced 60.78%	10,000 $251,000
Q4 2020 Feb 16, 2021	BUY	$10.12 - $13.94 $257,047 - $354,076	25,400 Added 25400.0%	25,500 $306,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $17.01 $748 - $1,701	100 New	100 $2,000
Q2 2019 Aug 14, 2019	SELL	$8.85 - $12.49 $348,690 - $492,106	-39,400 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.32 - $14.49 $1.6 Million - $2.24 Million	-154,900 Reduced 79.72%	39,400 $478,000
Q4 2018 Feb 14, 2019	BUY	$8.73 - $13.74 $824,985 - $1.3 Million	94,500 Added 94.69%	194,300 $2 Million
Q3 2018 Nov 14, 2018	BUY	$12.7 - $15.79 $1.21 Million - $1.51 Million	95,400 Added 2168.18%	99,800 $1.31 Million
Q2 2018 Aug 14, 2018	BUY	$10.99 - $44.21 $48,356 - $194,524	4,400 New	4,400 $64,000
Q1 2018 May 15, 2018	SELL	$27.95 - $45.04 $131,365 - $211,688	-4,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$35.44 - $63.76 $166,568 - $299,672	4,700	4,700 $176,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $678M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.